Literature DB >> 11347559

Medical treatment of uterine fibroids.

N F Chavez1, E A Stewart.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11347559     DOI： 10.1097/00003081-200106000-00023

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


× No keyword cloud information.
  5 in total

1.  [Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound].

Authors:  T Eckey; A Neumann; M K Bohlmann; J Barkhausen; P Hunold
Journal:  Radiologe       Date:  2011-07       Impact factor: 0.635

2.  Immunohistochemical analysis of collagen expression in uterine leiomyomata during the menstrual cycle.

Authors:  Masaaki Iwahashi; Yasuteru Muragaki; Makoto Ikoma; Yasushi Mabuchi; Aya Kobayashi; Yuuko Tanizaki; Kazuhiko Ino
Journal:  Exp Ther Med       Date:  2011-01-05       Impact factor: 2.447

3.  Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Authors:  Faezeh Koohestani; Wenan Qiang; Amy L MacNeill; Stacy A Druschitz; Vanida A Serna; Malavika Adur; Takeshi Kurita; Romana A Nowak
Journal:  Hum Reprod       Date:  2016-04-29       Impact factor: 6.918

4.  The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.

Authors:  Meagan M Grudzien; Philip Steven Low; Peter C Manning; Melissa Arredondo; Robert J Belton; Romana A Nowak
Journal:  Fertil Steril       Date:  2009-01-09       Impact factor: 7.329

Review 5.  Uterine fibroids in menopause and perimenopause.

Authors:  Mara Ulin; Mohamed Ali; Zunir Tayyeb Chaudhry; Ayman Al-Hendy; Qiwei Yang
Journal:  Menopause       Date:  2020-02       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.